A detailed history of Independence Bank Of Kentucky transactions in Abb Vie Inc. stock. As of the latest transaction made, Independence Bank Of Kentucky holds 16,521 shares of ABBV stock, worth $3.22 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
16,521
Previous 15,627 5.72%
Holding current value
$3.22 Million
Previous $2.85 Million 0.42%
% of portfolio
0.76%
Previous 0.86%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$154.79 - $180.76 $138,382 - $161,599
894 Added 5.72%
16,521 $2.83 Million
Q1 2024

Apr 16, 2024

BUY
$159.82 - $182.1 $654,782 - $746,063
4,097 Added 35.53%
15,627 $2.85 Million
Q4 2023

Jan 23, 2024

BUY
$137.6 - $154.97 $61,782 - $69,581
449 Added 4.05%
11,530 $1.79 Million
Q3 2023

Oct 16, 2023

BUY
$133.59 - $154.65 $23,244 - $26,909
174 Added 1.6%
11,081 $1.65 Million
Q2 2023

Jul 07, 2023

SELL
$132.51 - $164.9 $76,855 - $95,642
-580 Reduced 5.05%
10,907 $1.47 Million
Q1 2023

Apr 06, 2023

SELL
$144.61 - $166.54 $68,689 - $79,106
-475 Reduced 3.97%
11,487 $1.83 Million
Q4 2022

Jan 09, 2023

SELL
$138.31 - $165.87 $79,943 - $95,872
-578 Reduced 4.61%
11,962 $1.93 Million
Q3 2022

Oct 06, 2022

SELL
$134.21 - $153.93 $12,884 - $14,777
-96 Reduced 0.76%
12,540 $1.68 Million
Q2 2022

Jul 06, 2022

SELL
$137.62 - $174.96 $32,340 - $41,115
-235 Reduced 1.83%
12,636 $1.94 Million
Q1 2022

Apr 14, 2022

BUY
$131.98 - $163.75 $52,923 - $65,663
401 Added 3.22%
12,871 $2.09 Million
Q4 2021

Jan 26, 2022

SELL
$107.43 - $135.93 $32,229 - $40,779
-300 Reduced 2.35%
12,470 $1.69 Million
Q3 2021

Oct 26, 2021

SELL
$106.4 - $120.78 $1,702 - $1,932
-16 Reduced 0.13%
12,770 $1.38 Million
Q2 2021

Jul 23, 2021

SELL
$105.21 - $117.21 $28,091 - $31,295
-267 Reduced 2.05%
12,786 $1.44 Million
Q1 2021

Apr 21, 2021

SELL
$102.3 - $112.62 $12,173 - $13,401
-119 Reduced 0.9%
13,053 $1.41 Million
Q4 2020

Jan 22, 2021

SELL
$80.49 - $108.67 $53,525 - $72,265
-665 Reduced 4.81%
13,172 $1.41 Million
Q3 2020

Oct 05, 2020

BUY
$85.91 - $100.83 $27,319 - $32,063
318 Added 2.35%
13,837 $1.21 Million
Q2 2020

Jul 08, 2020

SELL
$73.37 - $98.18 $29,714 - $39,762
-405 Reduced 2.91%
13,519 $1.33 Million
Q1 2020

Apr 23, 2020

SELL
$64.5 - $97.79 $13,222 - $20,046
-205 Reduced 1.45%
13,924 $1.06 Million
Q4 2019

Jan 31, 2020

SELL
$72.13 - $90.25 $13,344 - $16,696
-185 Reduced 1.29%
14,129 $1.25 Million
Q3 2019

Oct 21, 2019

SELL
$62.98 - $75.72 $79,984 - $96,164
-1,270 Reduced 8.15%
14,314 $1.08 Million
Q2 2019

Jul 23, 2019

SELL
$65.7 - $83.98 $58,013 - $74,154
-883 Reduced 5.36%
15,584 $1.13 Million
Q1 2019

Apr 29, 2019

BUY
$77.14 - $90.79 $76,214 - $89,700
988 Added 6.38%
16,467 $1.33 Million
Q4 2018

Jan 28, 2019

BUY
$77.85 - $96.01 $66,172 - $81,608
850 Added 5.81%
15,479 $1.43 Million
Q3 2018

Oct 17, 2018

BUY
$88.91 - $98.84 $124,918 - $138,870
1,405 Added 10.62%
14,629 $1.38 Million
Q2 2018

Aug 07, 2018

BUY
$89.78 - $106.23 $448 - $531
5 Added 0.04%
13,224 $1.23 Million
Q1 2018

Apr 18, 2018

SELL
$92.01 - $123.21 $83,729 - $112,121
-910 Reduced 6.44%
13,219 $1.25 Million
Q4 2017

Feb 08, 2018

BUY
$89.56 - $98.21 $1.27 Million - $1.39 Million
14,129
14,129 $1.37 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Independence Bank Of Kentucky Portfolio

Follow Independence Bank Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Independence Bank Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Independence Bank Of Kentucky with notifications on news.